|
Foreword
Secretory cells require an expanded endoplasmic reticulum
(ER) to carry out their task. Efficient protein folding inevitably
leads to the accumulation of misfolded proteins as well, a normal
byproduct of the protein maturation process. Hence, specialized
secretory activity is accompanied by constant ER stress, constituting
a threat to the life of a cell. Adaptation to the stress of protein
misfolding is accomplished by the activation of a complex signaling
pathway known as the unfolded protein response (UPR). Genetic manipulation
of the UPR supports the notion that components of the pathway are
essential to sustain the function of secretory cells such as B lymphocytes
and pancreatic exocrine and endocrine cells.
Emerging evidence suggests that the occurrence of ER stress influences
diseases ranging from cancer to autoimmunity and diabetes. Perturbation
in organelle function has also been observed in many neurological
disorders related to protein misfolding and aggregation. Most neurodegenerative
disorders share a common neuropathology, primarily featuring the
presence of abnormal protein aggregates containing specific misfolded
proteins. These diseases include pathological conditions such as
amyotrophic lateral sclerosis (ALS), Alzheimer’s Disease (AD),
Parkinson’s Disease (PD), Prion-related Disorders (PrD), Huntington’s
Disease (HD), and others.
In this informative e-Book, Claudio Hetz has brought together experts
in the UPR to provide an overview of the emerging role of ER stress
and protein misfolding in different physiological and pathological
conditions. Several chapters focus on the role of the UPR in specific
diseases such as diabetes, cancer, and neurodegeneration; other
chapters discuss biochemical and genetic mechanisms underpinning
the UPR, autophagy and the ubiquitin-proteasome system. Auhors include
Amy Lee, an expert in chaperone biology and cancer; Randal Kaufman,
a pioneer in identifying the components of the UPR; Claudio Soto,
Hidenori Hichijo, and Takashi Momoi, experts in neurodegeneration
and protein misfolding, and many others. An important focus of the
book is considering the potential therapeutic benefits of targeting
ER stress pathways in the context of human disease. Readers interested
in understanding how a cell handles protein folding stress and the
consequences of dysregulation of this process for human disease
will find this book invaluable.
Laurie H. Glimcher, M.D.
Irene Heinz Given
Professor of Immunology
Harvard School of Public Health
Professor of Medicine
Harvard Medical School
|
|